EpiPen Maker Mylan Quietly Steers Effort to Protect Its Price

Friday, September 16, 2016 - 03:11 in Mathematics & Economics

Inclusion on a federal list would mean Mylan could keep its list price high — or even raise it — without patients complaining. But consumers would feel it indirectly.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net